{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:20:05Z","timestamp":1791804005874,"version":"4.3.4"},"reference-count":41,"publisher":"American Society of Hematology","issue":"11","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,11]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Elevated MAPK and the JAK-STAT signaling play pivotal roles in the pathogenesis of chronic neutrophilic leukemia and atypical chronic myeloid leukemia. Although inhibitors targeting these pathways effectively suppress the diseases, they fall short in providing enduring remission, largely attributed to the cytostatic nature of these drugs. Even combinations of these drugs are ineffective in achieving sustained remission. Enhanced MAPK signaling besides promoting proliferation and survival triggers a proapoptotic response. Consequently, malignancies reliant on elevated MAPK signaling use MAPK feedback regulators to intricately modulate the signaling output, prioritizing proliferation and survival while dampening the apoptotic stimuli. Herein, we demonstrate that enhanced MAPK signaling in granulocyte colony-stimulating factor 3 receptor (CSF3R)\u2013driven leukemia upregulates the expression of dual specificity phosphatase 1 (DUSP1) to suppress the apoptotic stimuli crucial for leukemogenesis. Consequently, genetic deletion of Dusp1 in mice conferred synthetic lethality to CSF3R-induced leukemia. Mechanistically, DUSP1 depletion in leukemic context causes activation of JNK1\/2 that results in induced expression of BIM and P53 while suppressing the expression of BCL2 that selectively triggers apoptotic response in leukemic cells. Pharmacological inhibition of DUSP1 by BCI (a DUSP1 inhibitor) alone lacked antileukemic activity due to ERK1\/2 rebound caused by off-target inhibition of DUSP6. Consequently, a combination of BCI with a MEK inhibitor successfully cured CSF3R-induced leukemia in a preclinical mouse model. Our findings underscore the pivotal role of DUSP1 in leukemic transformation driven by enhanced MAPK signaling and advocate for the development of a selective DUSP1 inhibitor for curative treatment outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023010830","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:55:50Z","timestamp":1711486550000},"page":"2765-2776","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation"],"prefix":"10.1182","volume":"8","author":[{"given":"Meenu","family":"Kesarwani","sequence":"first","affiliation":[{"name":"1Division of Pathology, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kincaid","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Azhar","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Azam","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"2Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"3Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"5","key":"2024061013552590100_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"10","key":"2024061013552590100_bib2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells10102509","article-title":"ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer","volume":"10","author":"Sugiura","year":"2021","journal-title":"Cells"},{"issue":"7","key":"2024061013552590100_bib3","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK signaling pathways in apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5240","key":"2024061013552590100_bib4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","volume":"270","author":"Xia","year":"1995","journal-title":"Science"},{"issue":"5","key":"2024061013552590100_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd2289","article-title":"Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses","volume":"6","author":"Jeffrey","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"2024061013552590100_bib6","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","volume":"73","author":"Lake","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2024061013552590100_bib7","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"issue":"19","key":"2024061013552590100_bib8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"2024061013552590100_bib9","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/leu.2016.376","article-title":"Enhanced MAPK signaling is essential for CSF3R-induced leukemia","volume":"31","author":"Rohrabaugh","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2024061013552590100_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41375-018-0188-8","article-title":"Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors","volume":"33","author":"Dwivedi","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"2024061013552590100_bib11","doi-asserted-by":"crossref","first-page":"C189","DOI":"10.1152\/ajpcell.00347.2009","article-title":"The dual-specificity MAP kinase phosphatases: critical roles in development and cancer","volume":"299","author":"Bermudez","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2024061013552590100_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbamcr.2018.09.002","article-title":"Dual-specificity MAP kinase phosphatases in health and disease","volume":"1866","author":"Seternes","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"8","key":"2024061013552590100_bib13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/bloodadvances.2022007486","article-title":"Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML","volume":"7","author":"Azhar","year":"2023","journal-title":"Blood Adv"},{"issue":"4","key":"2024061013552590100_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nm.4310","article-title":"Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia","volume":"23","author":"Kesarwani","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"2024061013552590100_bib15","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/MCB.20.5.1886-1896.2000","article-title":"Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway","volume":"20","author":"Breitschopf","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2024061013552590100_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2402090","article-title":"Phosphorylation of BCL2 and regulation of apoptosis","volume":"15","author":"Ruvolo","year":"2001","journal-title":"Leukemia"},{"issue":"43","key":"2024061013552590100_bib17","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","article-title":"Phosphorylation of BIM-EL by ERK1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function","volume":"22","author":"Luciano","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"2024061013552590100_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","article-title":"The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics","volume":"5","author":"Hata","year":"2015","journal-title":"Cancer Discov"},{"issue":"4","key":"2024061013552590100_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molcel.2008.03.025","article-title":"Multisite phosphorylation regulates BIM stability and apoptotic activity","volume":"30","author":"Hubner","year":"2008","journal-title":"Mol Cell"},{"issue":"29","key":"2024061013552590100_bib20","doi-asserted-by":"crossref","first-page":"26715","DOI":"10.1074\/jbc.M303264200","article-title":"Cross-talk between JNK\/SAPK and ERK\/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors","volume":"278","author":"Shen","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"2024061013552590100_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajh.25688","article-title":"Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management","volume":"95","author":"Szuber","year":"2020","journal-title":"Am J Hematol"},{"issue":"22","key":"2024061013552590100_bib22","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood-2013-06-509976","article-title":"The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition","volume":"122","author":"Fleischman","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2024061013552590100_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.2019000611","article-title":"Genomic landscape of neutrophilic leukemias of ambiguous diagnosis","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"issue":"6","key":"2024061013552590100_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2016-10-695981","article-title":"Genomics of chronic neutrophilic leukemia","volume":"129","author":"Maxson","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2024061013552590100_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO.19.00895","article-title":"Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia","volume":"38","author":"Dao","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2024061013552590100_bib26","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/s41375-021-01278-2","article-title":"Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia","volume":"35","author":"Carratt","year":"2021","journal-title":"Leukemia"},{"issue":"12","key":"2024061013552590100_bib27","first-page":"e414","article-title":"Durable disease control with MEK inhibition in a patient with NRAS-mutated atypical chronic myeloid leukemia","volume":"7","author":"Khanna","year":"2015","journal-title":"Cureus"},{"issue":"3","key":"2024061013552590100_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/cdd.2008.148","article-title":"Tumour cell survival signalling by the ERK1\/2 pathway","volume":"16","author":"Balmanno","year":"2009","journal-title":"Cell Death Differ"},{"issue":"6","key":"2024061013552590100_bib29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/cdd.2011.198","article-title":"Alternative splicing of BIM and ERK-mediated BIM(EL) phosphorylation are dispensable for hematopoietic homeostasis in\u00a0vivo","volume":"19","author":"Clybouw","year":"2012","journal-title":"Cell Death Differ"},{"issue":"1","key":"2024061013552590100_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1742-4658.2009.07367.x","article-title":"ERK and cell death: ERK1\/2 in neuronal death","volume":"277","author":"Subramaniam","year":"2010","journal-title":"FEBS J"},{"issue":"1","key":"2024061013552590100_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1742-4658.2009.07368.x","article-title":"ERK and cell death: ERK location and T cell selection","volume":"277","author":"Teixeiro","year":"2010","journal-title":"FEBS J"},{"issue":"1","key":"2024061013552590100_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J"},{"issue":"8","key":"2024061013552590100_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41375-023-01959-0","article-title":"MAPK-negative feedback regulation confers dependence to JAK2(V617F) signaling","volume":"37","author":"Kesarwani","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"2024061013552590100_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.cr.7290262","article-title":"Role of JNK activation in apoptosis: a double-edged sword","volume":"15","author":"Liu","year":"2005","journal-title":"Cell Res"},{"issue":"39","key":"2024061013552590100_bib35","doi-asserted-by":"crossref","first-page":"28395","DOI":"10.1074\/jbc.M705142200","article-title":"Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress","volume":"282","author":"Teng","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"2024061013552590100_bib36","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/sj.emboj.7601723","article-title":"ERK1\/2-dependent phosphorylation of BIMEL promotes its rapid dissociation from Mcl-1 and Bcl-xL","volume":"26","author":"Ewings","year":"2007","journal-title":"EMBO J"},{"issue":"18","key":"2024061013552590100_bib37","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4161\/cc.6.18.4728","article-title":"BIM and the pro-survival Bcl-2 proteins: opposites attract, ERK repels","volume":"6","author":"Ewings","year":"2007","journal-title":"Cell Cycle"},{"issue":"21","key":"2024061013552590100_bib38","doi-asserted-by":"crossref","first-page":"18811","DOI":"10.1074\/jbc.M301010200","article-title":"Activation of the ERK1\/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, BIM","volume":"278","author":"Ley","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"2024061013552590100_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.cdd.4400998","article-title":"Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins","volume":"9","author":"Puthalakath","year":"2002","journal-title":"Cell Death Differ"},{"issue":"6","key":"2024061013552590100_bib40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00355-6","article-title":"JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis","volume":"38","author":"Putcha","year":"2003","journal-title":"Neuron"},{"issue":"524","key":"2024061013552590100_bib41","doi-asserted-by":"crossref","first-page":"eaao4170","DOI":"10.1126\/scisignal.aao4170","article-title":"Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK","volume":"11","author":"Wolf","year":"2018","journal-title":"Sci Signal"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/11\/2765\/2228455\/blooda_adv-2023-010830-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/11\/2765\/2228455\/blooda_adv-2023-010830-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T13:56:00Z","timestamp":1718027760000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/11\/2765\/515498\/Enhanced-MAPK-signaling-induced-by-CSF3R-mutants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010830","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}